What Is a Catalyst in Investing? How to Find and Use Them

Written by Jim Norris · NorrisAI AlphaLens · Updated August 2026

Quick answer: A catalyst is a specific upcoming event that could materially change the market's perception of a stock's value — an earnings report, product launch, FDA approval, merger announcement, regulatory decision, or management change. Catalysts matter because even a correctly valued stock can sit at a discount indefinitely without a catalyst to close the gap. Identifying the specific catalyst that could unlock value — and assessing its probability and timing — is a key part of building a complete investment thesis.

Why catalysts matter

Value investing legend Benjamin Graham noted that the market is a weighing machine in the long run — but "long run" can mean years or even decades. A stock can trade below intrinsic value for extended periods if there's no near-term reason for the market to revalue it.

Catalysts are the mechanisms that close the gap between price and value. Without a plausible catalyst, a "cheap" stock may simply stay cheap. With a clear catalyst, the timeline for value realization becomes more concrete and the investment thesis more complete.

Types of catalysts

Earnings catalysts

The most common and most predictable in timing. An upcoming earnings report where you have a differentiated view from consensus — either because you believe the market is underestimating earnings power or overestimating headwinds — creates a near-term catalyst.

Product and operational catalysts

New product launches, capacity expansions, plant openings, geographic expansions, or technology transitions that could meaningfully change the revenue trajectory or cost structure.

Regulatory and legal catalysts

FDA approvals for drug companies, regulatory approvals for acquisitions, resolution of litigation, or changes in regulations that affect an industry's competitive dynamics.

Corporate action catalysts

Mergers and acquisitions, spinoffs, management changes, activist investor involvement, share buyback announcements, or dividend initiations.

Macro catalysts

Interest rate decisions, changes in commodity prices, currency moves, or policy changes that disproportionately affect specific companies or sectors.

Howard Marks has noted that identifying a catalyst isn't enough — you also need to assess the probability that it happens on the timeline you expect, and how the market is currently pricing that probability. A catalyst that's already fully priced in offers no edge; one the market is underweighting is where opportunity lies.

How to think about catalyst probability

For each potential catalyst, ask:

• What's the probability it happens? A product launch from a company with a strong execution track record is more certain than an FDA approval for a drug in Phase 2 trials.
• What's the timeline? A catalyst expected in 3 months creates very different investment dynamics than one expected in 3 years.
• How does the market currently price it? If the market is pricing a 90% probability on a binary event, the upside from being right is small and the downside from being wrong is large.
• What happens if the catalyst doesn't occur? The best investments are worth owning even without the catalyst — the catalyst is upside, not the entire thesis.

Catalyst risk: when the catalyst fails

Binary catalysts — particularly drug approvals, litigation outcomes, or regulatory decisions — carry the risk of total failure. A biotech stock trading at $20 in anticipation of an FDA approval may fall to $5 if the approval is rejected. Sizing positions in catalyst-driven situations appropriately for this binary risk is essential.

The safest catalyst-driven investments are ones where the underlying business is worth owning regardless of the catalyst outcome — where the catalyst is accelerant rather than the entire thesis.

Professor Aswath Damodaran of NYU Stern Business School emphasizes building catalysts into valuation through scenario analysis — assigning probabilities to different outcomes and weighting the resulting values. This forces explicit thinking about catalyst probability rather than vague optimism. — The Little Book of Valuation, Wiley

How AlphaLens maps catalysts

The Catalyst Calendar — framework #9 — maps upcoming events for any stock: earnings dates, product launches, regulatory decisions, conference presentations, and key macro events that could affect the business. It combines this with the broader thesis to answer: what specific events could close the gap between current price and estimated value, and on what timeline?

Where to go deeper

For a detailed walkthrough of each research framework, see the complete guide to all 15 AlphaLens frameworks.

For definitions of investing terms, see the AlphaLens investing glossary.